Oxciva (Oxacillin)

Oxacillin, the active ingredient in Oxciva, is a beta‑lactam antibiotic presented as a 500 mg tablet for oral use. It treats infections caused by susceptible Gram‑positive bacteria, particularly in skin, bone and respiratory sites, and is commonly prescribed for adults and children. GNH USA supplies Oxciva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxacillin is a beta‑lactam antibiotic used to manage infections caused by penicillin‑resistant Staphylococcus aureus and related organisms. - Skin and soft‑tissue infections: Reduces bacterial load and promotes healing. - Bone and joint infections (osteomyelitis): Assists in eradicating deep‑seated infection. - Respiratory tract infections: Helps clear pneumonia and bronchitis caused by susceptible strains.

Oxacillin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea or vomiting - Diarrhea - Rash or mild skin eruption - Elevated liver enzymes - Headache - Local irritation at injection site (if administered parenterally)

Serious or Rare Side Effects: - Anaphylaxis or severe allergic reaction - Clostridioides difficile‑associated colitis - Hemolytic anemia - Severe liver injury - Neutropenia or agranulocytosis - Acute interstitial nephritis

When using Oxacillin, several safety considerations should be observed. - Renal impairment: Adjust dose or monitor renal function. - Hepatic dysfunction: Monitor liver enzymes during therapy. - History of beta‑lactam allergy: Evaluate risk before prescribing. - Concomitant use of oral anticoagulants: May increase INR. - Pregnancy and lactation: Use only if clearly beneficial and under the … - Store at ambient  ":  \